Abstract
We examined whether a specific aminopeptidase P (APP) inhibitor, apstatin, increases vasodepressor responses to bradykinin in anaesthetized rats, and whether it would augment blood pressure responses further after treatment with the angiotensin-converting enzyme inhibitor (ACEi), lisinopril. Apstatin doubled the maximum blood pressure response to bradykinin. The area under the curve (AUC), which incorporates both peak blood pressure changes and duration of response, was doubled in apstatin-treated rats vs controls and in the apstatin+lisinopril group vs lisinopril alone. These data demonstrate that APP is an important kinase in vivo.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Holtzman E. J., Pillay G., Rosenthal T., Yaron A. Aminopeptidase P activity in rat organs and human serum. Anal Biochem. 1987 May 1;162(2):476–484. doi: 10.1016/0003-2697(87)90423-4. [DOI] [PubMed] [Google Scholar]
- Hooper N. M., Hryszko J., Oppong S. Y., Turner A. J. Inhibition by converting enzyme inhibitors of pig kidney aminopeptidase P. Hypertension. 1992 Mar;19(3):281–285. doi: 10.1161/01.hyp.19.3.281. [DOI] [PubMed] [Google Scholar]
- Ishida H., Scicli A. G., Carretero O. A. Role of angiotensin converting enzyme and other peptidases in in vivo metabolism of kinins. Hypertension. 1989 Sep;14(3):322–327. doi: 10.1161/01.hyp.14.3.322. [DOI] [PubMed] [Google Scholar]
- Simmons W. H., Orawski A. T. Membrane-bound aminopeptidase P from bovine lung. Its purification, properties, and degradation of bradykinin. J Biol Chem. 1992 Mar 5;267(7):4897–4903. [PubMed] [Google Scholar]
- Ward P. E., Chow A., Drapeau G. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P. Biochem Pharmacol. 1991 Jul 25;42(4):721–727. doi: 10.1016/0006-2952(91)90028-4. [DOI] [PubMed] [Google Scholar]
- Wiemer G., Schölkens B. A., Linz W. Endothelial protection by converting enzyme inhibitors. Cardiovasc Res. 1994 Feb;28(2):166–172. doi: 10.1093/cvr/28.2.166. [DOI] [PubMed] [Google Scholar]